JP2024529907A5 - - Google Patents
Info
- Publication number
- JP2024529907A5 JP2024529907A5 JP2024502644A JP2024502644A JP2024529907A5 JP 2024529907 A5 JP2024529907 A5 JP 2024529907A5 JP 2024502644 A JP2024502644 A JP 2024502644A JP 2024502644 A JP2024502644 A JP 2024502644A JP 2024529907 A5 JP2024529907 A5 JP 2024529907A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- cells
- monoclonal antibody
- mct11
- exhausted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163223473P | 2021-07-19 | 2021-07-19 | |
| US63/223,473 | 2021-07-19 | ||
| PCT/US2022/073903 WO2023004326A1 (en) | 2021-07-19 | 2022-07-19 | Mct11 antibodies to treat t cell functional exhaustion and enhance cancer immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529907A JP2024529907A (ja) | 2024-08-14 |
| JP2024529907A5 true JP2024529907A5 (enExample) | 2025-07-17 |
Family
ID=84979783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502644A Pending JP2024529907A (ja) | 2021-07-19 | 2022-07-19 | Ｔ細胞機能の疲弊を処置し、がん免疫療法を強化するためのｍｃｔ１１抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250084159A1 (enExample) |
| EP (1) | EP4373858A4 (enExample) |
| JP (1) | JP2024529907A (enExample) |
| AU (1) | AU2022314744A1 (enExample) |
| CA (1) | CA3226568A1 (enExample) |
| WO (1) | WO2023004326A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024206930A2 (en) * | 2023-03-30 | 2024-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules targeting lymph node progenitor exhausted t cells and methods of use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2246427T3 (pl) * | 2008-02-08 | 2017-06-30 | Immunas Pharma, Inc. | Przeciwciała zdolne do wiązania się swoiście do oligomerów amyloidu beta i ich stosowanie |
| EP2763692A2 (en) * | 2011-10-06 | 2014-08-13 | European Molecular Biology Laboratory | Use of igf-1 in the modulation of treg cell activity and the treatment and prevention of autoimmune disorders or diseases |
| GB201501017D0 (en) * | 2014-12-23 | 2015-03-04 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers |
| US11104724B2 (en) * | 2016-05-23 | 2021-08-31 | New York University | Compositions and methods for antibodies targeting staphylococcal leukotoxins |
| US12048717B2 (en) * | 2016-06-03 | 2024-07-30 | University of Pittsburgh—of the Commonwealth System of Higher Education | Use of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) agonists to improve ex vivo expansion of tumor infiltrating lymphocytes (TILS) |
| US11471462B2 (en) * | 2016-06-27 | 2022-10-18 | The Broad Institute, Inc. | Compositions and methods for detecting and treating diabetes |
-
2022
- 2022-07-19 CA CA3226568A patent/CA3226568A1/en active Pending
- 2022-07-19 EP EP22846797.3A patent/EP4373858A4/en active Pending
- 2022-07-19 US US18/580,741 patent/US20250084159A1/en active Pending
- 2022-07-19 JP JP2024502644A patent/JP2024529907A/ja active Pending
- 2022-07-19 AU AU2022314744A patent/AU2022314744A1/en active Pending
- 2022-07-19 WO PCT/US2022/073903 patent/WO2023004326A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7520072B2 (ja) | Ｐｄ－ｌ１特異的抗体およびそれを使用する方法 | |
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP6767362B2 (ja) | リンパ球における阻害経路の中和 | |
| AU2020363041B2 (en) | Antibodies against the poliovirus receptor (PVR) and uses thereof | |
| JP2020501531A5 (enExample) | ||
| JP2018533371A5 (enExample) | ||
| JP2022502052A5 (enExample) | ||
| JP2023540526A5 (enExample) | ||
| JP2021524478A5 (enExample) | ||
| JP2018500014A5 (enExample) | ||
| JP2022533538A5 (enExample) | ||
| JP2018532383A5 (enExample) | ||
| JP2023549537A5 (enExample) | ||
| HRP20191083T1 (hr) | Molekule antitijela za tim-3 i njihove upotrebe | |
| JP2022553922A5 (enExample) | ||
| JP2019512207A5 (enExample) | ||
| JP2022514734A5 (enExample) | ||
| CN112292399A (zh) | 抗cd27抗体及其用途 | |
| JP2024506315A5 (enExample) | ||
| JP2021529776A5 (enExample) | ||
| JP2024515560A5 (enExample) | ||
| JP2024512135A5 (enExample) | ||
| JP2023517754A5 (enExample) | ||
| JP2022526856A5 (enExample) | ||
| JP2025516590A5 (enExample) |